Login / Signup
Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction.
Nils Schroeter
Sabine Ahrendt
Anna Hager
Michel Rijntjes
Published in:
Movement disorders clinical practice (2020)
Keyphrases
</>
parkinson disease
low dose
deep brain stimulation
mesenchymal stem cells
replacement therapy